RSV

Infectious Disease

81 drugs in development·18 companies·2 clinical trials

Drug Pipeline by Phase

Approved(3)

Drug	Company
enflonsia	Merck & Co., Inc. (MRK)
ID NOW® rapid molecular system	ABBOTT LABORATORIES (ABT)
mRESVIA	Moderna, Inc. (MRNA)

Phase 3(9)

Drug	Company
hepatitis b vaccine	Sanofi (SNY)
high dose rsvt vaccine	Sanofi (SNY)
low dose rsvt vaccine	Sanofi (SNY)
measles mumps	Sanofi (SNY)
palivizumab	ASTRAZENECA PLC (AZN)
rsvt vaccine	Sanofi (SNY)
standard dose rsvt vaccine	Sanofi (SNY)
streptococcus pneumoniae vaccine	Sanofi (SNY)
varicella virus vaccine	Sanofi (SNY)

Phase 2(12)

Drug	Company
diphtheria	Sanofi (SNY)
EDP-323 Dose Regimen 1	ENANTA PHARMACEUTICALS INC (ENTA)
EDP-323 Dose Regimen 2	ENANTA PHARMACEUTICALS INC (ENTA)
EDP-938	ENANTA PHARMACEUTICALS INC (ENTA)
FOLFIRI regimen	ENANTA PHARMACEUTICALS INC (ENTA)
ivx-121	Icosavax, Inc. (ICVX)
measles	Sanofi (SNY)
nv-387	NANOVIRICIDES, INC. (NNVC)
obeldesivir	Phoenix Life Sciences International Limited. (PLSI)
RI-001	ADMA BIOLOGICS, INC. (ADMA)
rotavirus vaccine	Sanofi (SNY)
Zelicapavir (formerly EDP-938)	ENANTA PHARMACEUTICALS INC (ENTA)

Phase 1(44)

Drug	Company
Caffeine	ENANTA PHARMACEUTICALS INC (ENTA)
carbamazepine	ENANTA PHARMACEUTICALS INC (ENTA)
EDP-323	ENANTA PHARMACEUTICALS INC (ENTA)
fluconazole	ENANTA PHARMACEUTICALS INC (ENTA)
h5 flu imp 10	Sanofi (SNY)
h5 flu imp 10	Sanofi (SNYNF)
h5 flu imp 11	Sanofi (SNYNF)
h5 flu imp 11	Sanofi (SNY)
h5 flu imp 12	Sanofi (SNY)
h5 flu imp 12	Sanofi (SNYNF)
h5 flu imp 2	Sanofi (SNYNF)
h5 flu imp 2	Sanofi (SNY)
h5 flu imp 3	Sanofi (SNY)
h5 flu imp 3	Sanofi (SNYNF)
h5 flu imp 7	Sanofi (SNYNF)
h5 flu imp 7	Sanofi (SNY)
h5 flu imp 8	Sanofi (SNY)
h5 flu imp 8	Sanofi (SNYNF)
h5 flu imp 9	Sanofi (SNYNF)
h5 flu imp 9	Sanofi (SNY)
h5 flu investigational medical product 1	Sanofi (SNY)
h5 flu investigational medical product 1	Sanofi (SNYNF)
Itraconazole	ENANTA PHARMACEUTICALS INC (ENTA)
Midazolam	ENANTA PHARMACEUTICALS INC (ENTA)
monovalent rsv vaccine	Sanofi (SNY)
moxifloxacin	ENANTA PHARMACEUTICALS INC (ENTA)
Quinidine	ENANTA PHARMACEUTICALS INC (ENTA)
Rosuvastatin	ENANTA PHARMACEUTICALS INC (ENTA)
rsv imp 4	Sanofi (SNY)
rsv imp 4	Sanofi (SNYNF)
rsv imp 5	Sanofi (SNYNF)
rsv imp 5	Sanofi (SNY)
rsv imp 6	Sanofi (SNY)
rsv imp 6	Sanofi (SNYNF)
rsv/hmpv vaccine dose a1	Sanofi (SNY)
rsv/hmpv vaccine dose a2	Sanofi (SNY)
rsv/hmpv vaccine dose a3	Sanofi (SNY)
rsv/hmpv vaccine dose b1	Sanofi (SNY)
rsv/hmpv vaccine dose b2	Sanofi (SNY)
rsv/hmpv vaccine dose b3	Sanofi (SNY)
rsv/hmpv vaccine dose c1	Sanofi (SNY)
rsv/hmpv vaccine dose c2	Sanofi (SNY)
rsv/hmpv vaccine dose c3	Sanofi (SNY)
zelicapavir	ENANTA PHARMACEUTICALS INC (ENTA)

Preclinical(7)

Drug	Company
AR-201	Aridis Pharmaceuticals, Inc. (ARDS)
co-dx pcr flu a/b	Co-Diagnostics Inc. (CODX)
gv2311	GENVEC INC (GNVC)
rsv vaccine	GENVEC INC (GNVC)
rsv vaccine	MYMETICS CORP (MYMX)
tri	Decoy Therapeutics Inc. (DCOY)
vby329	Invivyd, Inc. (IVVD)

Unknown(1)

Drug	Company
Alinity® m and m2000™	ABBOTT LABORATORIES (ABT)

Phase 1/Phase 2(2)

Drug	Company
high-dose rsv mrna vaccine	SINOVAC BIOTECH LTD (SVA)
low-dose rsv mrna vaccine	SINOVAC BIOTECH LTD (SVA)

Phase 4(3)

Drug	Company
nirsevimab	Sanofi (SNY)
nirsevimab	Sanofi (SNYNF)
nirsevimab respiratory syncytial virus monoclonal antibody	Sanofi (SNY)

BioSniper tracks 81 drugs in development for RSV across 18 companies.

There are 2 clinical trials targeting RSV tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.